Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glia orchestrate neural circuit development.

Developmental cell·2026
Same author

Right on cue-Neuronal signals guide myelination in the developing cortex.

Developmental cell·2026
Same author

Enhancing myelination in a high-poxic environment.

Neuron·2026
Same author

Next-gen micropillars for investigating oligodendrocyte myelination.

Nature methods·2026
Same author

Environmental considerations in human genomic data governance: overcoming normative challenges.

BMC medical ethics·2026
Same author

Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis.

Nature medicine·2025

Related Experiment Video

Updated: Dec 30, 2025

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.6K

That Wasn't a Complement-Too Much C3 in Demyelinating Disease.

Wendy Xin1, Jonah R Chan1

  • 1Department of Neurology and the Weill Institute for Neuroscience, University of California, San Francisco, San Francisco, CA 94158, USA.

Immunity
|January 18, 2020
PubMed
Summary

Microglia excessively prune synapses in early multiple sclerosis, causing damage. Inhibiting complement component C3 rescues this synaptic loss in demyelinating disease.

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.1K
Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

7.6K

Related Experiment Videos

Last Updated: Dec 30, 2025

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.6K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.1K
Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

7.6K

Area of Science:

  • Neuroimmunology
  • Central nervous system disorders
  • Demyelinating diseases

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease.
  • MS pathology involves demyelination and neurodegeneration in the central nervous system (CNS).
  • Microglia, the resident immune cells of the CNS, play a critical role in MS pathogenesis.

Purpose of the Study:

  • To investigate the role of microglial activity in early demyelinating disease.
  • To identify mechanisms driving synaptic loss during demyelination.
  • To explore therapeutic strategies targeting microglial function in MS.

Main Methods:

  • Utilized mouse models of demyelinating disease.
  • Assessed microglial pruning activity using advanced imaging techniques.
  • Quantified synaptic density and integrity.
  • Investigated the impact of complement component C3 inhibition.

Main Results:

  • Observed excessive synaptic pruning by microglia in early stages of demyelination.
  • Demonstrated a direct link between microglial pruning and synaptic loss.
  • Showed that inhibiting complement component C3 significantly reduced aberrant microglial pruning.
  • Confirmed rescue of synaptic loss upon C3 inhibition.

Conclusions:

  • Excessive microglial pruning is a key driver of early synaptic loss in demyelinating conditions like MS.
  • Complement component C3 mediates this pathological pruning.
  • Targeting C3 offers a potential therapeutic avenue for preserving synapses in MS.